Table 2.
THA indication, n (%) | Coxarthrosis | 11 (73.3) |
Post-traumatic coxarthrosis | 2 (13.3) | |
Hip dysplasias | 1 (6.7) | |
AVN of femoral head | 1 (6.7) | |
Bearing surfaces, n (%) | MoM | 12 (80) |
MoP | 3 (20) | |
Mean (range) implant survivorship (years) | MoM | 6.9 (2–10) |
MoP | 18.3 (14–22) | |
Tot. | 9.2 (2–22) |